Related Experiment Video
Updated: Nov 1, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
microRNA-17 is a tumor suppressor in oral squamous cell carcinoma and is repressed by LSD1
Kaixin Wangzhou1, Wanren Fu2, Mengmeng Li3
1School of Management, Hainan Medical University, Haikou, China.
Objective:
The effects of epigenetic modifiers have been uncovered on cellular reprogramming and, specifically, on sustaining characteristics of cancer stem cells. We here aim to investigate whether lysine-specific demethylase 1 (LSD1) affects the development of oral squamous cell carcinoma (OSCC) by sustaining the cancer stem cells from OSCC (OSCSCs).
Methods:
RT-qPCR detection was firstly conducted to screen out research gene by determining differential expression of histone demethylases and methylases in identified OSCSCs. Then, microarray analysis was carried out in cells with poor expression of LSD1.
Results:
OSCSCs expressed high levels of LSD1, and LSD1 inhibition reduced cell viability, migration, invasion, and sphere formation of OSCSCs. Later mechanistic studies suggested that LSD1 inhibited microRNA (miR)-17 expression through histone demethylation. miR-17 bound to KPNA2, and LSD1 downstream genes were mainly enriched in the PI3K/AKT pathway. Importantly, miR-17 inhibitor reversed the inhibitory effect of si-LSD1 on cell activity, while si-KPNA2 abolished the promotive effect of miR-17 inhibitor on cell activity both in vitro and in vivo.
Conclusion:
Overall, LSD1 functions as a cancer stem cell supporter in OSCC by catalyzing demethylation of miR-17 and activating the downstream KPNA2/PI3K/AKT pathway, which contributes to understanding of the mechanisms associated with epigenetic regulation in OSCC.
Insights
Lysine-specific demethylase 1 (LSD1) supports oral squamous cell carcinoma (OSCC) stem cells by regulating miR-17 and the KPNA2/PI3K/AKT pathway, impacting OSCC development.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic modifiers influence cellular reprogramming and cancer stem cell (CSC) characteristics.
- Lysine-specific demethylase 1 (LSD1) is implicated in various cancers.
- Cancer stem cells (CSCs) drive tumor initiation and progression.
Purpose of the Study:
- To investigate the role of LSD1 in oral squamous cell carcinoma (OSCC) development.
- To determine if LSD1 sustains OSCC cancer stem cells (OSCSCs).
Main Methods:
- RT-qPCR to screen differentially expressed histone-modifying enzymes in OSCSCs.
- Microarray analysis in cells with low LSD1 expression.
- In vitro and in vivo experiments to assess cell activity and pathway modulation.
Main Results:
- OSCSCs exhibit high LSD1 levels; LSD1 inhibition reduces OSCSC viability, migration, invasion, and sphere formation.
- LSD1 demethylates histone to inhibit microRNA-17 (miR-17) expression.
- miR-17 targets KPNA2, with downstream genes enriched in the PI3K/AKT pathway.
- Modulation of LSD1, miR-17, and KPNA2 affects OSCSC activity.
Conclusions:
- LSD1 promotes OSCC by sustaining OSCSCs.
- LSD1's mechanism involves miR-17 demethylation and activation of the KPNA2/PI3K/AKT pathway.
- This study enhances understanding of epigenetic regulation in OSCC.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Induced Pluripotent Stem Cells
Somatic...

